Iris Maimon

Iris Maimon is currently the Project Leader at BiomX since June 2023. Prior to this role, they served as the Director of Drug Development at Salzman Group from November 2020 to September 2022. They also held various positions at Salzman Group, including Director of Commercial Services, Director of Pharmacology, and Principal Scientist. Iris Maimon completed a PhD in Biology at Weizmann Institute of Science from 2003 to 2008, followed by a Master of Science in Yeast genetics from Technion - Israel Institute of Technology from 2001 to 2003, and a Bachelor of Science in Molecular Biochemistry from Technion - Israel Institute of Technology from 1998 to 2001. Additionally, they have experience as a Senior Intern and Post doc at the Weizmann Institute of Science.